These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 27254403

  • 1. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).
    Alamo C, López-Muñoz F, Sánchez-García J.
    Actas Esp Psiquiatr; 2016 May; 44(3):107-12. PubMed ID: 27254403
    [Abstract] [Full Text] [Related]

  • 2. Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species.
    Arnsten AFT.
    Neurobiol Learn Mem; 2020 Dec; 176():107327. PubMed ID: 33075480
    [Abstract] [Full Text] [Related]

  • 3. Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.
    Bilder RM, Loo SK, McGough JJ, Whelan F, Hellemann G, Sugar C, Del'Homme M, Sturm A, Cowen J, Hanada G, McCracken JT.
    J Am Acad Child Adolesc Psychiatry; 2016 Aug; 55(8):667-73. PubMed ID: 27453080
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.
    Michelini G, Lenartowicz A, Vera JD, Bilder RM, McGough JJ, McCracken JT, Loo SK.
    J Am Acad Child Adolesc Psychiatry; 2023 Apr; 62(4):415-426. PubMed ID: 35963559
    [Abstract] [Full Text] [Related]

  • 5. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Childress AC.
    Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723
    [Abstract] [Full Text] [Related]

  • 6. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Cutler AJ, Brams M, Bukstein O, Mattingly G, McBurnett K, White C, Rubin J.
    J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1092-101. PubMed ID: 25245353
    [Abstract] [Full Text] [Related]

  • 7. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions.
    Fukuyama K, Nakano T, Shiroyama T, Okada M.
    Int J Mol Sci; 2021 Apr 16; 22(8):. PubMed ID: 33923533
    [Abstract] [Full Text] [Related]

  • 8. Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
    Mattes JA.
    J Am Acad Psychiatry Law; 2016 Jun 16; 44(2):151-7. PubMed ID: 27236168
    [Abstract] [Full Text] [Related]

  • 9. The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Sallee FR.
    Postgrad Med; 2010 Sep 16; 122(5):78-87. PubMed ID: 20861591
    [Abstract] [Full Text] [Related]

  • 10. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
    Arnsten AF, Pliszka SR.
    Pharmacol Biochem Behav; 2011 Aug 16; 99(2):211-6. PubMed ID: 21295057
    [Abstract] [Full Text] [Related]

  • 11. Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
    Rizzo R, Martino D.
    Expert Rev Neurother; 2015 Apr 16; 15(4):347-54. PubMed ID: 25800130
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
    Kawaura K, Karasawa J, Chaki S, Hikichi H.
    Behav Brain Res; 2014 Aug 15; 270():349-56. PubMed ID: 24882610
    [Abstract] [Full Text] [Related]

  • 13. A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Sallee F, Connor DF, Newcorn JH.
    J Child Adolesc Psychopharmacol; 2013 Jun 15; 23(5):308-19. PubMed ID: 23782125
    [Abstract] [Full Text] [Related]

  • 14. Evaluating Guanfacine Hydrochloride in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adult Patients: Design, Development and Place in Therapy.
    Ota T, Yamamuro K, Okazaki K, Kishimoto T.
    Drug Des Devel Ther; 2021 Jun 15; 15():1965-1969. PubMed ID: 34007156
    [Abstract] [Full Text] [Related]

  • 15. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
    Loo SK, Bilder RM, Cho AL, Sturm A, Cowen J, Walshaw P, Levitt J, Del'Homme M, Piacentini J, McGough JJ, McCracken JT.
    J Am Acad Child Adolesc Psychiatry; 2016 Aug 15; 55(8):674-682.e1. PubMed ID: 27453081
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents.
    Childress A, Hoo-Cardiel A, Lang P.
    Expert Opin Pharmacother; 2020 Mar 15; 21(4):417-426. PubMed ID: 31971448
    [Abstract] [Full Text] [Related]

  • 17. Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.
    Huss M, Chen W, Ludolph AG.
    Clin Drug Investig; 2016 Jan 15; 36(1):1-25. PubMed ID: 26585576
    [Abstract] [Full Text] [Related]

  • 18. Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).
    Sallee FR, Eaton K.
    Expert Opin Pharmacother; 2010 Oct 15; 11(15):2549-56. PubMed ID: 20831361
    [Abstract] [Full Text] [Related]

  • 19. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
    Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA.
    Clin Ther; 2013 Nov 15; 35(11):1778-93. PubMed ID: 24139092
    [Abstract] [Full Text] [Related]

  • 20. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF.
    CNS Drugs; 2009 Nov 15; 23 Suppl 1():33-41. PubMed ID: 19621976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.